首页> 外国专利> STABLE VECTOR OF CONSTITUTIONALLY HIGH EXPRESSION FOR OBTAINING HPV VACCINES AND RECOMBINANT LACTIC-ACID BACTERIA TRANSFORMED WITH THIS VECTOR

STABLE VECTOR OF CONSTITUTIONALLY HIGH EXPRESSION FOR OBTAINING HPV VACCINES AND RECOMBINANT LACTIC-ACID BACTERIA TRANSFORMED WITH THIS VECTOR

机译:稳定的高表达载体,可用于获得HPV疫苗和经此载体转化的重组乳酸菌

摘要

1. The surface expression vector for the production of vaccines against human papillomavirus (HPV), including a gene encoding a mutant protein repE having the amino acid sequence of SEQ ID NO: 1, a promoter, a complex gene of poly-gamma-glutamate synthetase and a gene that is linked to a complex gene poly-gamma-glutamate synthetase and encodes an antigenic protein of the human papillomavirus associated with tumor induction. 2. The surface expression vector of claim 1, wherein the HPV antigen protein associated with the induction of the tumor is HPV E7 or E7 (Rb) protein. The surface expression vector according to claim 1, wherein the promoter is an aldolase promoter derived from lactic acid bacteria. The surface expression vector of claim 1, wherein the poly-gamma-glutamate synthetase complex gene is selected from the group consisting of pgsB, pgsC and pgsA. The recombinant microorganism transformed by the vector according to claim 1.6. The recombinant microorganism according to claim 1, which is a lactic acid bacteria. A vaccine for the treatment of cervical cancer, comprising a transformed recombinant microorganism according to claim 5 or 6 as an active ingredient. A method for producing a microorganism containing an HPV antigen that is expressed on its surface, the method comprising the steps of: cultivating a recombinant microorganism according to claim 5 for expressing an HPV antigen on the surface of a microorganism; and collecting a recombinant microorganism containing the HPV antigen that is expressed on its surface. A vaccine for the treatment of cervical cancer, including a transformed recombinant microorganism containing the HPV antigen as an active ingredient,
机译:1.用于生产抗人乳头瘤病毒(HPV)的疫苗的表面表达载体,其包括编码具有SEQ ID NO:1的氨基酸序列的突变蛋白repE的基因,启动子,聚γ-谷氨酸的复合基因。合成酶和与复杂基因聚γ-谷氨酸合成酶连接并编码与肿瘤诱导相关的人乳头瘤病毒抗原蛋白的基因。 2.权利要求1的表面表达载体,其中与肿瘤诱导相关的HPV抗原蛋白是HPV E7或E7(Rb)蛋白。 2.根据权利要求1所述的表面表达载体,其中,所述启动子是来源于乳酸菌的醛缩酶启动子。 2.根据权利要求1所述的表面表达载体,其中,所述聚γ-谷氨酸合成酶复合基因选自由pgsB,pgsC和pgsA组成的组。根据权利要求1.6的载体转化的重组微生物。 2.根据权利要求1所述的重组微生物,其为乳酸菌。 7.一种用于治疗宫颈癌的疫苗,其包含根据权利要求5或6的转化的重组微生物作为活性成分。 6.一种产生在其表面表达的含有HPV抗原的微生物的方法,该方法包括以下步骤:培养根据权利要求5所述的重组微生物以在其表面表达HPV抗原;收集含有在其表面表达的HPV抗原的重组微生物。一种用于治疗宫颈癌的疫苗,包括含有HPV抗原作为有效成分的转化重组微生物,

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号